标题
Cytochrome P450 variations in different ethnic populations
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 8, Issue 3, Pages 371-382
出版商
Informa Healthcare
发表日期
2012-01-31
DOI
10.1517/17425255.2012.657626
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5
- (2011) Rüdiger Kaspera et al. BIOCHEMICAL PHARMACOLOGY
- Lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatment
- (2011) In Hae Park et al. BREAST CANCER RESEARCH AND TREATMENT
- A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients
- (2011) L. Elens et al. CLINICAL CHEMISTRY
- Genetic determinants of platelet response to clopidogrel
- (2011) Aldona Kubica et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes
- (2010) Madhu S. Singh et al. BREAST
- Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations
- (2010) Rasmus S. Pedersen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
- (2010) Giovanna Gentile et al. JOURNAL OF HEADACHE AND PAIN
- NewCYP2A6gene deletion and conversion variants in a population of Black African descent
- (2010) Jill C Mwenifumbo et al. PHARMACOGENOMICS
- Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer
- (2010) T K Bergmann et al. PHARMACOGENOMICS JOURNAL
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
- (2010) D Wang et al. PHARMACOGENOMICS JOURNAL
- Insights into the Substrate Specificity, Inhibitors, Regulation, and Polymorphisms and the Clinical Impact of Human Cytochrome P450 1A2
- (2009) Shu-Feng Zhou et al. AAPS Journal
- Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis
- (2009) Betti Giusti et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Substrate Specificity, Regulation, and Polymorphism of Human Cytochrome P450 2B6
- (2009) Sui-Lin Mo et al. CURRENT DRUG METABOLISM
- Polymorphism of human cytochrome P450 enzymes and its clinical impact
- (2009) Shu-Feng Zhou et al. DRUG METABOLISM REVIEWS
- Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
- (2009) D. Sibbing et al. EUROPEAN HEART JOURNAL
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and nevirapine
- (2009) G. Ramachandran et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genetic Polymorphism in Cytochrome P450 2D6 (CYP2D6): Population Distribution of CYP2D6 Activity
- (2009) Patricia Neafsey et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
- SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions
- (2009) Saskia Preissner et al. NUCLEIC ACIDS RESEARCH
- Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
- (2009) Johanna Sistonen et al. Pharmacogenetics and Genomics
- Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies
- (2009) Elizabeth B Daily et al. PHARMACOGENOMICS
- Pharmacogenomics ofCYP3A: considerations for HIV treatment
- (2009) Sukhwinder S Lakhman et al. PHARMACOGENOMICS
- CYP2C9*8is prevalent among African–Americans: implications for pharmacogenetic dosing
- (2009) Stuart A Scott et al. PHARMACOGENOMICS
- Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome
- (2009) B Laika et al. PHARMACOGENOMICS JOURNAL
- Global variation in CYP2C8–CYP2C9 functional haplotypes
- (2009) William C Speed et al. PHARMACOGENOMICS JOURNAL
- Polymorphisms of human cytochrome P450 2C9 and the functional relevance
- (2009) Shu-Feng Zhou et al. TOXICOLOGY
- Comparing Genetic Ancestry and Self-Described Race in African Americans Born in the United States and in Africa
- (2008) R. Yaeger et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CYP2B6: New Insights into a Historically Overlooked Cytochrome P450 Isozyme
- (2008) Hongbing Wang et al. CURRENT DRUG METABOLISM
- The role of African American ethnicity and metabolism in sentinel polychlorinated biphenyl congener serum levels
- (2008) Joseph E. McGraw et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients
- (2008) Petra Bohanec Grabar et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Cytochrome P450 2C19 genetic polymorphisms in Ugandans
- (2008) Jun Miura et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam
- (2008) M. I. Veiga et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent
- (2008) Jill C. Mwenifumbo et al. HUMAN MUTATION
- The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response
- (2008) Patrick Gladding et al. JACC-Cardiovascular Interventions
- Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver
- (2008) M. H. Hofmann et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents
- (2008) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
- (2008) Dennis A. Hesselink et al. Pharmacogenetics and Genomics
- 4??-Hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians
- (2008) Ulf Diczfalusy et al. Pharmacogenetics and Genomics
- Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
- (2008) Arzu Gunes et al. PHARMACOGENOMICS
- Cytochrome P450 Enzyme Polymorphism Frequency in Indigenous and Native American Populations: A Systematic Review
- (2008) Cheedy Jaja et al. Public Health Genomics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search